The combination of ATRA and arsenic with varying amounts of chemotherapy has been studied in newly diagnosed APL patients. Iland et al report one of the best outcomes observed in APL studies using ATRA plus arsenic during induction and consolidation with 4 doses of idarubicin in induction only. Professional illustration by Noel Sirivansanti/Xavier Studio.